[HTML][HTML] Thrombopoietin receptor agonists: ten years later
The two thrombopoietin receptor agonists (TPO-RA), eltrombopag and romiplostim, were
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …
Thrombopoietin receptor agonists: ten years later
W Ghanima, N Cooper, F Rodeghiero… - …, 2019 - fondazioneematologia.it
The two thrombopoietin receptor agonists (TPO-RA), eltrombopag and romiplostim, were
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …
Thrombopoietin receptor agonists: ten years later
W Ghanima, N Cooper, F Rodeghiero… - …, 2019 - pubmed.ncbi.nlm.nih.gov
The two thrombopoietin receptor agonists (TPO-RA), eltrombopag and romiplostim, were
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …
[PDF][PDF] Thrombopoietin receptor agonists: ten years later
W GHANIMA - haematologica, 2019 - legeforeningen.no
TThe two thrombopoietin receptor agonists (TPO-RA), eltrombopag and romiplostim, were
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …
[引用][C] Thrombopoietin receptor agonists: ten years later
W Ghanima, N Cooper, F Rodeghiero, B Godeau… - Haematologica, 2019 - cir.nii.ac.jp
[HTML][HTML] Thrombopoietin receptor agonists: ten years later
W Ghanima, N Cooper, F Rodeghiero… - …, 2019 - haematologica.org
The two thrombopoietin receptor agonists (TPO-RA), eltrombopag and romiplostim, were
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …
Thrombopoietin receptor agonists: ten years later.
W Ghanima, N Cooper, F Rodeghiero, B Godeau… - …, 2019 - europepmc.org
The two thrombopoietin receptor agonists (TPO-RA), eltrombopag and romiplostim, were
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …
[HTML][HTML] Thrombopoietin receptor agonists: ten years later
W Ghanima, N Cooper, F Rodeghiero… - …, 2019 - haematologica.org
The two thrombopoietin receptor agonists (TPO-RA), eltrombopag and romiplostim, were
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …
Thrombopoietin receptor agonists: ten years later.
W Ghanima, N Cooper, F Rodeghiero, B Godeau… - …, 2019 - europepmc.org
The two thrombopoietin receptor agonists (TPO-RA), eltrombopag and romiplostim, were
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …
Thrombopoietin receptor agonists: ten years later
W Ghanima, N Cooper, F Rodeghiero… - …, 2019 - fondazioneematologia.it
The two thrombopoietin receptor agonists (TPO-RA), eltrombopag and romiplostim, were
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …
licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then …